The FDA has decided to reconsider its recent ban on the sale of compounded versions of tirzepatide, according to court documents obtained by Becker’s.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA to reconsider decision barring sale of compounded Mounjaro: 5 things to know
